Health
Ignored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health
The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research shows a troubling connection between the severity of obstructive sleep apnea (OSA) during REM sleep and increased risk of verbal memory decline in older adults—an early indicator of Alzheimer's disease. (1) This is where key specialists like Vivos Therapeutics step in, offering focused treatments to fight OSA and its other ramifications.
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a significant, modifiable risk factor. Interrupted breathing during sleep can impair memory and accelerate cognitive decline, with growing evidence linking poor sleep to an increased risk of dementia. In response, Vivos Therapeutics is offering innovative, airway-centered treatments aimed at improving sleep quality and supporting long-term brain health.","length":484,"tagName":"p"},{"type":"text","content":"LITTLETON, Colo., July 22, 2025 /PRNewswire/ -- The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research shows a troubling connection between the severity of obstructive sleep apnea (OSA) during REM sleep and increased risk of verbal memory decline in older adults—an early indicator of Alzheimer's disease. (1) This is where key specialists like Vivos Therapeutics step in, offering focused treatments to fight OSA and its other ramifications.","length":515,"tagName":"p"},{"type":"image","alt":"VIVOS Therapeutics logo","displaySize":"","headline":null,"caption":"VIVOS Therapeutics logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":357,"height":357,"url":"https://media.zenfs.com/en/prnewswire.com/e59a3e90621d4e6cf6382df718e242bf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iWEK5rFeE3jknDqeIpBNTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/e59a3e90621d4e6cf6382df718e242bf","width":357,"height":357}},"href":"https://mma.prnewswire.com/media/2735460/VIVOS_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""These findings not only underscore the urgent need for early intervention in OSA but also present a critical opportunity to modify previously intractable risk factors and potentially alter the devastating trajectory of cognitive decline", states Kirk Huntsman, CEO of Vivos Therapeutics, a leading innovator in medical technology for sleep and breathing health.","length":372,"tagName":"p"},{"type":"text","content":"An Alarming Link and Its Ramifications ","length":38,"tagName":"p"},{"type":"text","content":"The UC Irvine study that links dementia with OSA delivers a powerful and sobering message: a direct and concerning ...